Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -15,222 | N/A | N/A | N/A |
| Depreciation Amortization | 1,511 | N/A | N/A | N/A |
| Accounts receivable | -1,034 | N/A | N/A | N/A |
| Other Working Capital | -3,738 | N/A | N/A | N/A |
| Other Operating Activity | 3,433 | 0 | 0 | 0 |
| Operating Cash Flow | $-15,050 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Purchase Sale Intangibles | -189 | N/A | N/A | N/A |
| Other Investing Activity | -189 | 0 | 0 | 0 |
| Investing Cash Flow | $-189 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | -1,009 | N/A | N/A | N/A |
| Common Stock Issued | 8,713 | N/A | N/A | N/A |
| Other Financing Activity | -1,106 | 0 | 0 | 0 |
| Financing Cash Flow | $6,598 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 946 | N/A | N/A | N/A |
| Beginning Cash Position | 22,495 | N/A | N/A | N/A |
| End Cash Position | 14,800 | N/A | N/A | N/A |
| Net Cash Flow | $-7,695 | $N/A | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -15,050 | N/A | N/A | N/A |
| Free Cash Flow | -15,050 | 0 | 0 | 0 |